Merlin Biosciences

Merlin Biosciences is a specialized venture investor targeting on life science companies. It makes equity investments on behalf of its investment partnerships. Since 1997, Merlin has invested in 27 European biotechnology companies. It is raising its third investment partnership, the Merlin Biosciences Fund III, L.P., and advises funds with €400 million of equity capital. It has a world-wide, loyal network of advisers and experienced strategic partners. Merlin invests in companies that are bringing to market human medicines or medical devices with groundbreaking technology and great commercial potential. It has a reputation as an attractive partner for management teams who can create substantial value for investors. Merlin Biosciences Limited is authorized and regulated in the United Kingdom by the Financial Services Authority.